294 related articles for article (PubMed ID: 29272474)
1. Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
Waljee AK; Lipson R; Wiitala WL; Zhang Y; Liu B; Zhu J; Wallace B; Govani SM; Stidham RW; Hayward R; Higgins PDR
Inflamm Bowel Dis; 2017 Dec; 24(1):45-53. PubMed ID: 29272474
[TBL] [Abstract][Full Text] [Related]
2. Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease.
Gan RW; Sun D; Tatro AR; Cohen-Mekelburg S; Wiitala WL; Zhu J; Waljee AK
PLoS One; 2021; 16(9):e0257520. PubMed ID: 34543353
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines.
Waljee AK; Sauder K; Patel A; Segar S; Liu B; Zhang Y; Zhu J; Stidham RW; Balis U; Higgins PDR
J Crohns Colitis; 2017 Jul; 11(7):801-810. PubMed ID: 28333183
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
Waljee AK; Wiitala WL; Govani S; Stidham R; Saini S; Hou J; Feagins LA; Khan N; Good CB; Vijan S; Higgins PD
PLoS One; 2016; 11(6):e0158017. PubMed ID: 27336296
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.
Noureldin M; Higgins PDR; Govani SM; Cohen-Mekelburg S; Kenney BC; Stidham RW; Waljee JF; Waljee AK
Aliment Pharmacol Ther; 2019 Jan; 49(1):74-83. PubMed ID: 30430615
[TBL] [Abstract][Full Text] [Related]
6. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Ban L; Tata LJ; Fiaschi L; Card T
Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
[TBL] [Abstract][Full Text] [Related]
7. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
Govani SM; Wiitala WL; Stidham RW; Saini SD; Hou JK; Feagins LA; Sussman JB; Higgins PD; Waljee AK
Inflamm Bowel Dis; 2016 Aug; 22(8):1923-8. PubMed ID: 27416039
[TBL] [Abstract][Full Text] [Related]
8. Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study.
Shafer LA; Walker JR; Chhibba T; Targownik LE; Singh H; Ivekovic M; Bernstein CN
Inflamm Bowel Dis; 2019 Nov; 25(12):1996-2005. PubMed ID: 31087034
[TBL] [Abstract][Full Text] [Related]
9. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.
deFonseka AM; Tuskey A; Conaway MR; Behm BW
J Clin Gastroenterol; 2016 Aug; 50(7):578-83. PubMed ID: 26368297
[TBL] [Abstract][Full Text] [Related]
11. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
12. Prediction of In-hospital Mortality in Emergency Department Patients With Sepsis: A Local Big Data-Driven, Machine Learning Approach.
Taylor RA; Pare JR; Venkatesh AK; Mowafi H; Melnick ER; Fleischman W; Hall MK
Acad Emerg Med; 2016 Mar; 23(3):269-78. PubMed ID: 26679719
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
Sahyoun LC; Fetene J; McMillan C; Protiva P; Al Bawardy B; Gaidos JKJ; Proctor D
Dig Dis Sci; 2024 May; 69(5):1654-1660. PubMed ID: 38466459
[TBL] [Abstract][Full Text] [Related]
14. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
Campos S; Portela F; Sousa P; Sofia C
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
[TBL] [Abstract][Full Text] [Related]
16. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
[TBL] [Abstract][Full Text] [Related]
17. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
18. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Khan N; Vallarino C; Lissoos T; Darr U; Luo M
Drugs Aging; 2017 Nov; 34(11):859-868. PubMed ID: 29170864
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.
Javaid A; Shahab O; Adorno W; Fernandes P; May E; Syed S
Inflamm Bowel Dis; 2022 Jun; 28(6):819-829. PubMed ID: 34417815
[TBL] [Abstract][Full Text] [Related]
20. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
